FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904689263> ?p ?o ?g. }

• W2904689263 endingPage "1529" @default.
• W2904689263 startingPage "1525" @default.
• W2904689263 abstract "Fragility fracture significantly increases risk of future fracture. The fragility fracture cycle should be disrupted. The secondary fracture prevention is important for the patients with fragility hip fracture. The pharmacotherapy for osteoporosis is important for prevention of new fracture. However, many patients with hip fracture do not receive osteoporosis treatment. This retrospective study investigates the influence of bone mineral density (BMD) assessment on the initiation of anti-osteoporosis medications in the hospitalized patients with fragility hip fracture.This retrospective research enrolled 1211 patients with fragility hip fracture 50 years of age and older. Among 1211 patients aged from 50 to 103 years with the average age of 77.83 ± 9.95 years, there were 807 females and 404 males. There were 634 fractures of femoral neck and 577 intertrochanteric fractures of femur. We examined whether patients had received bone mineral density assessment and received anti-osteoporosis therapy during the period of hospitalization. The patients were divided into BMD assessment group and no BMD assessment group. Measurement data were expressed as mean ± standard deviation and compared with t test. All parameters of groups were compared with Chi-square test.Of 1211 patients, 331 (27.33%) had received BMD assessment and 925 (76.38%) had received anti-osteoporosis drugs during the period of hospitalization. The rate of bisphosphonate use was lower and only 11.31% in the total patients. The anti-osteoporosis treatment rate was 93.66% in the patients receiving BMD assessment and 69.89% in the patients without BMD assessment (p < 0.01). The zoledronate use significantly increased from 6.7% in the patients without BMD assessment to 23.56% in the patients receiving BMD assessment (p < 0.01).BMD assessment is a good basis for communication between patients and orthopedic surgeons. BMD assessment significantly increases the initiation of osteoporosis treatment and bisphosphonate use in the patients with hip fracture during the period of hospitalization." @default.
• W2904689263 created "2018-12-22" @default.
• W2904689263 creator A5004272413 @default.
• W2904689263 creator A5004623139 @default.
• W2904689263 creator A5005802011 @default.
• W2904689263 creator A5012398288 @default.
• W2904689263 creator A5022040282 @default.
• W2904689263 creator A5023547621 @default.
• W2904689263 creator A5024615515 @default.
• W2904689263 creator A5041680185 @default.
• W2904689263 creator A5069230386 @default.
• W2904689263 date "2018-12-17" @default.
• W2904689263 modified "2023-10-18" @default.
• W2904689263 title "Influence of bone densitometry on the anti-osteoporosis treatment after fragility hip fracture" @default.
• W2904689263 cites W1908729563 @default.
• W2904689263 cites W1992243532 @default.
• W2904689263 cites W2014744106 @default.
• W2904689263 cites W2016830665 @default.
• W2904689263 cites W2026972932 @default.
• W2904689263 cites W2034355079 @default.
• W2904689263 cites W2052405168 @default.
• W2904689263 cites W2065137888 @default.
• W2904689263 cites W2072925975 @default.
• W2904689263 cites W2076478367 @default.
• W2904689263 cites W2078523825 @default.
• W2904689263 cites W2089611054 @default.
• W2904689263 cites W2102702396 @default.
• W2904689263 cites W2107490395 @default.
• W2904689263 cites W2110396808 @default.
• W2904689263 cites W2126074691 @default.
• W2904689263 cites W2223260488 @default.
• W2904689263 cites W2256962519 @default.
• W2904689263 cites W2343993798 @default.
• W2904689263 cites W2587229819 @default.
• W2904689263 cites W2605743908 @default.
• W2904689263 cites W2620314581 @default.
• W2904689263 doi "https://doi.org/10.1007/s40520-018-1094-7" @default.
• W2904689263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6763573" @default.
• W2904689263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30560430" @default.
• W2904689263 hasPublicationYear "2018" @default.
• W2904689263 type Work @default.
• W2904689263 sameAs 2904689263 @default.
• W2904689263 citedByCount "11" @default.
• W2904689263 countsByYear W29046892632019 @default.
• W2904689263 countsByYear W29046892632020 @default.
• W2904689263 countsByYear W29046892632021 @default.
• W2904689263 countsByYear W29046892632023 @default.
• W2904689263 crossrefType "journal-article" @default.
• W2904689263 hasAuthorship W2904689263A5004272413 @default.
• W2904689263 hasAuthorship W2904689263A5004623139 @default.
• W2904689263 hasAuthorship W2904689263A5005802011 @default.
• W2904689263 hasAuthorship W2904689263A5012398288 @default.
• W2904689263 hasAuthorship W2904689263A5022040282 @default.
• W2904689263 hasAuthorship W2904689263A5023547621 @default.
• W2904689263 hasAuthorship W2904689263A5024615515 @default.
• W2904689263 hasAuthorship W2904689263A5041680185 @default.
• W2904689263 hasAuthorship W2904689263A5069230386 @default.
• W2904689263 hasBestOaLocation W29046892631 @default.
• W2904689263 hasConcept C126322002 @default.
• W2904689263 hasConcept C136496925 @default.
• W2904689263 hasConcept C141071460 @default.
• W2904689263 hasConcept C167135981 @default.
• W2904689263 hasConcept C2775854910 @default.
• W2904689263 hasConcept C2776541429 @default.
• W2904689263 hasConcept C2776886416 @default.
• W2904689263 hasConcept C2777251235 @default.
• W2904689263 hasConcept C2778885795 @default.
• W2904689263 hasConcept C2779329777 @default.
• W2904689263 hasConcept C3019131272 @default.
• W2904689263 hasConcept C71924100 @default.
• W2904689263 hasConceptScore W2904689263C126322002 @default.
• W2904689263 hasConceptScore W2904689263C136496925 @default.
• W2904689263 hasConceptScore W2904689263C141071460 @default.
• W2904689263 hasConceptScore W2904689263C167135981 @default.
• W2904689263 hasConceptScore W2904689263C2775854910 @default.
• W2904689263 hasConceptScore W2904689263C2776541429 @default.
• W2904689263 hasConceptScore W2904689263C2776886416 @default.
• W2904689263 hasConceptScore W2904689263C2777251235 @default.
• W2904689263 hasConceptScore W2904689263C2778885795 @default.
• W2904689263 hasConceptScore W2904689263C2779329777 @default.
• W2904689263 hasConceptScore W2904689263C3019131272 @default.
• W2904689263 hasConceptScore W2904689263C71924100 @default.
• W2904689263 hasFunder F4320335520 @default.
• W2904689263 hasIssue "10" @default.
• W2904689263 hasLocation W29046892631 @default.
• W2904689263 hasLocation W29046892632 @default.
• W2904689263 hasLocation W29046892633 @default.
• W2904689263 hasLocation W29046892634 @default.
• W2904689263 hasOpenAccess W2904689263 @default.
• W2904689263 hasPrimaryLocation W29046892631 @default.
• W2904689263 hasRelatedWork W2018550867 @default.
• W2904689263 hasRelatedWork W2059944559 @default.
• W2904689263 hasRelatedWork W2141528524 @default.
• W2904689263 hasRelatedWork W2330928655 @default.
• W2904689263 hasRelatedWork W2338173161 @default.
• W2904689263 hasRelatedWork W2473849338 @default.
• W2904689263 hasRelatedWork W2563286383 @default.
• W2904689263 hasRelatedWork W2904689263 @default.

• next